IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.

RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.

Midroc Europe led a round that increzased the wave energy technology developer's total equity funding to $25m.

Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.

The pension fund will pay an undisclosed sum for a 2% stake in API Holdings, the owner of online drugstore PharmEasy backed by Ascent Health and Medi Assist.

Satt Paris-Saclay portfolio company EG 427 has collected $14m in its first funding round.

Siemens’ Next47 subsidiary has returned to back the unmanned aerial vehicle technology producer’s latest round, valuing it above $1bn.